Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of cyamemazine and an atypical neuroleptic

Combination of cyamemazine and an atypical neuroleptic

US Patent 6720318 · Granted Apr 13, 2004

Estimated economic value: $9,050,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or 2009
Combination of cyamemazine and an atypical neuroleptic2006
Combination of cyamemazine and an atypical neuroleptic2006
Use of nicergoline in the treatment of spasticity2004
Riluzole and alpha-tocopherol combination2003
Therapeutic application of nicergoline2002
Therapeutic use of 1,6-dimethyl-8&bgr;-hydroxymethyl-10&agr;-methoxyergoline2002
Use of riluzole or its salts for the prevention and treatment of adrenoleukodyst2002
Use of nicergoline for treating spasticity2002
Therapeutic use of 1, 6-dimethyl-8&bgr;-hydroxymethyl-10-&agr;-methoxyergoline2002
Method for the prevention or treatment of a motoneuron disease2001